Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA.
Mol Microbiol. 2010 Jul;77(2):300-23. doi: 10.1111/j.1365-2958.2010.07205.x. Epub 2010 Jun 7.
The distribution of PBP5, the major D,D-carboxypeptidase in Escherichia coli, was mapped by immunolabelling and by visualization of GFP fusion proteins in wild-type cells and in mutants lacking one or more D,D-carboxypeptidases. In addition to being scattered around the lateral envelope, PBP5 was also concentrated at nascent division sites prior to visible constriction. Inhibiting PBP2 activity (which eliminates wall elongation) shifted PBP5 to midcell, whereas inhibiting PBP3 (which aborts divisome invagination) led to the creation of PBP5 rings at positions of preseptal wall formation, implying that PBP5 localizes to areas of ongoing peptidoglycan synthesis. A PBP5(S44G) active site mutant was more evenly dispersed, indicating that localization required enzyme activity and the availability of pentapeptide substrates. Both the membrane bound and soluble forms of PBP5 converted pentapeptides to tetrapeptides in vitro and in vivo, and the enzymes accepted the same range of substrates, including sacculi, Lipid II, muropeptides and artificial substrates. However, only the membrane-bound form localized to the developing septum and restored wild-type rod morphology to shape defective mutants, suggesting that the two events are related. The results indicate that PBP5 localization to sites of ongoing peptidoglycan synthesis is substrate dependent and requires membrane attachment.
PBP5(主要的 D,D-羧肽酶)在大肠杆菌中的分布通过免疫标记和 GFP 融合蛋白在野生型细胞和缺乏一种或多种 D,D-羧肽酶的突变体中的可视化来进行定位。除了分布在侧膜周围,PBP5 还在可见的收缩之前集中在新生的分裂部位。抑制 PBP2 活性(消除细胞壁伸长)将 PBP5 转移到中隔,而抑制 PBP3(终止分裂体内陷)导致在预隔膜形成位置形成 PBP5 环,表明 PBP5 定位于正在进行肽聚糖合成的区域。PBP5(S44G)活性位点突变体分布更均匀,表明定位需要酶活性和五肽底物的可用性。膜结合和可溶性形式的 PBP5 均可在体外和体内将五肽转化为四肽,并且这些酶接受相同范围的底物,包括囊泡、脂质 II、肽聚糖和人工底物。然而,只有膜结合形式定位于正在发育的隔膜,并恢复野生型棒状形态缺陷突变体,表明这两个事件是相关的。结果表明,PBP5 定位于正在进行的肽聚糖合成部位是底物依赖性的,需要膜附着。